Niels Fristrup clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   DARENCA4 · Folic Acid Supplement Versus Placebo for Treating…DARENCA4 · Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

   Trial completed

   Also in this update: Final enrollment: 84 participants (planned 100); Study completion date changed from estimate of Sep 1, 2029 to Sep 22, 2026

   Niels Fristrup·Phase 2· NCT03581773· Registry history of NCT03581773 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

2. Minor

   NORDIC-SUN · Deferred Cytoreductive Nephrectomy in Synchronous…NORDIC-SUN · Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

   Trial sites expanded: 6 → 11 locations

   Niels Fristrup·Not applicable· NCT03977571· Registry history of NCT03977571 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.